Beca, J., Majeed, H., Chan, K. K., Hotte, S. J., Loblaw, A. and Hoch, J. S. (2019) “Cost-effectiveness of docetaxel in high-volume hormone-sensitive metastatic prostate cancer”, Canadian Urological Association Journal, 13(12), pp. 396–403. doi: 10.5489/cuaj.5889.